10,003 Kimberly-Clark Corporation $KMB Shares Acquired by GRIMES & Co WEALTH MANAGEMENT LLC

Key Points

• GRIMES & Co Wealth Management increased its Kimberly-Clark position by 7.1% in the third quarter, acquiring 10,003 shares and bringing its holdings to 150,072 shares valued at approximately $14.6 million.
• Institutional ownership remains substantial at 76.29%, with major investors including BlackRock, Thornburg Investment Management, Bank of New York Mellon, and Legal & General recently establishing or increasing positions.
• Kimberly-Clark shares rose 0.3% to open at $108.25, while the company’s latest quarterly results missed expectations on both earnings and revenue. Analysts maintain a consensus “Hold” rating with an average price target of $111.56.

GRIMES & Co WEALTH MANAGEMENT LLC boosted its position in Kimberly-Clark Corporation (NASDAQ:KMB - Free Report) by 7.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 150,072 shares of the company's stock after buying an additional 10,003 shares during the period. GRIMES & Co WEALTH MANAGEMENT LLC's holdings in Kimberly-Clark were worth $14,621,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. BlackRock Inc. acquired a new position in shares of Kimberly-Clark in the 2nd quarter valued at about $3,547,915,000. Thornburg Investment Management Inc. bought a new stake in shares of Kimberly-Clark during the 2nd quarter valued at about $632,373,000. Bank of New York Mellon Corp acquired a new stake in Kimberly-Clark during the second quarter worth approximately $239,612,000. Legal & General Group Plc acquired a new stake in Kimberly-Clark during the second quarter worth approximately $223,668,000. Finally, Diamond Hill Capital Management LLC Investment Advisor bought a new stake in Kimberly-Clark in the second quarter worth approximately $188,902,000. 76.29% of the stock is currently owned by institutional investors and hedge funds.

Kimberly-Clark News Summary

Here are the key news stories impacting Kimberly-Clark this week:

• Positive Sentiment: Kenvue acquisition completed: Kimberly-Clark closed the transaction on November 2, adding well-known brands including Tylenol and bringing together 10 billion-dollar brands across complementary consumer-health and personal-care categories. The deal is intended to create a larger, more diversified global consumer-health company. Kimberly-Clark Completes Acquisition of Kenvue
• Positive Sentiment: Large synergy opportunity: Management reiterated anticipated run-rate synergies of approximately $2.1 billion and said it already has a value-capture plan and pipeline. Successful integration and cost savings could support earnings growth and help Kimberly-Clark maintain its long record of dividend increases. Kimberly-Clark Completes Kenvue Acquisition
• Neutral Sentiment: Business transformation: The transaction marks a new chapter for KMB and changes the company’s exposure across consumer staples, healthcare and major stock indexes. The broader portfolio may improve diversification, but investors will be watching how quickly Kenvue contributes to results. Kimberly-Clark Closes Kenvue Acquisition
• Negative Sentiment: Significant financial commitment: The enterprise value of the acquisition is estimated at nearly $49 billion, increasing execution, financing and integration risks. Investors may also expect near-term pressure as Kimberly-Clark absorbs the deal and works to realize promised synergies. Kimberly-Clark Acquires Kenvue
• Negative Sentiment: Q3 concerns: Analysts expect weak consumer spending and rising costs to weigh on the upcoming quarter, although product innovation and efficiency gains could provide partial support. The earnings report will offer an early indication of operating momentum before the acquisition’s benefits are fully reflected. Kimberly-Clark Q3 Earnings Preview

Kimberly-Clark Trading Up 0.3%

Shares of KMB stock opened at $108.25 on Tuesday. The company has a debt-to-equity ratio of 3.45, a quick ratio of 0.69 and a current ratio of 0.91. The company has a market capitalization of $36.00 billion, a price-to-earnings ratio of 14.55, a PEG ratio of 5.86 and a beta of 0.25. The company has a 50-day simple moving average of $102.80 and a two-hundred day simple moving average of $103.07. Kimberly-Clark Corporation has a 52-week low of $92.42 and a 52-week high of $116.82.

Kimberly-Clark (NASDAQ:KMB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.80 earnings per share for the quarter, missing the consensus estimate of $2.01 by ($0.21). The business had revenue of $4.19 billion during the quarter, compared to analysts' expectations of $4.22 billion. Kimberly-Clark had a return on equity of 143.92% and a net margin of 11.79%. The firm's revenue for the quarter was up .6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.92 EPS. Research analysts anticipate that Kimberly-Clark Corporation will post 6.83 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on KMB shares. DA Davidson boosted their price target on Kimberly-Clark from $106.00 to $116.00 and gave the company a "neutral" rating in a research note on Wednesday, August 5th. Canaccord Genuity Group started coverage on shares of Kimberly-Clark in a research report on Friday, October 23rd. They set a "hold" rating and a $105.00 price objective for the company. Wells Fargo & Company lowered their price objective on shares of Kimberly-Clark from $105.00 to $100.00 and set an "equal weight" rating for the company in a research note on Monday, October 5th. BNP Paribas Exane lifted their price objective on shares of Kimberly-Clark from $101.00 to $110.00 and gave the company a "neutral" rating in a research note on Friday, October 16th. Finally, Seaport Research Partners raised shares of Kimberly-Clark to a "buy" rating in a research note on Tuesday, August 4th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, twelve have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Kimberly-Clark currently has an average rating of "Hold" and a consensus target price of $111.56.

About Kimberly-Clark

Kimberly-Clark Corporation NASDAQ: KMB is a global consumer products company that develops and markets personal care, tissue and professional hygiene products. Its portfolio includes products for babies and children, feminine care, adult care, family care and workplace hygiene.

The company's well-known brands include Huggies diapers and wipes, Kleenex facial tissue, Cottonelle bathroom tissue, Scott toilet paper and paper towels, Kotex feminine care products, and Depend, Poise and GoodNites products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.